Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease

被引：0
|
作者：
Zhao-Xia Yang
Wei Shen
Hang Sun
机构：
[1] The Second Affiliated Hospital Chongqing Medical University,Department of Gastroenterology and Hepatology
[2] Institute for Viral Hepatitis of Chongqing Medical University,undefined
[3] Chongqing Medical University,undefined
来源：
Hepatology International | 2010年 / 4卷
关键词：
FXR; Human; NAFLD; Lipid metabolism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：741 / 748
页数：7
相关论文
共 50 条
  • [31] Increased serum liver X receptor ligand oxysterols in patients with non-alcoholic fatty liver disease
    Tadashi Ikegami
    Hideyuki Hyogo
    Akira Honda
    Teruo Miyazaki
    Katsutoshi Tokushige
    Etsuko Hashimoto
    Kazuo Inui
    Yasushi Matsuzaki
    Susumu Tazuma
    Journal of Gastroenterology, 2012, 47 : 1257 - 1266
  • [32] Puerarin ameliorates non-alcoholic fatty liver disease by inhibiting lipid metabolism through FMO5
    Li, Zhaoyi
    Cao, Wenjing
    Zhang, Yuxuan
    Lai, Shanglei
    Ye, Yingyan
    Bao, Jianfeng
    Fu, Ai
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [33] Circadian Clock Genes in the Metabolism of Non-alcoholic Fatty Liver Disease
    Shi, Dongmei
    Chen, Jie
    Wang, Jiaofeng
    Yao, Jianfeng
    Huang, Yiqin
    Zhang, Gansheng
    Bao, Zhijun
    FRONTIERS IN PHYSIOLOGY, 2019, 10
  • [34] Liver biopsy complication rates in patients with non-alcoholic fatty liver disease
    Zhou, Felix
    Stueck, Ashley
    McLeod, Magnus
    CANADIAN LIVER JOURNAL, 2021, : 106 - 112
  • [35] Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD)
    Saeed, Ali
    Dullaart, Robin P. F.
    Schreuder, Tim C. M. A.
    Blokzijl, Hans
    Faber, Klaas Nico
    NUTRIENTS, 2018, 10 (01)
  • [36] Organismal Fructose Metabolism in Health and Non-Alcoholic Fatty Liver Disease
    Skenderian, Shea
    Park, Grace
    Jang, Cholsoon
    BIOLOGY-BASEL, 2020, 9 (11): : 1 - 17
  • [37] Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism
    Lefere, Sander
    Tacke, Frank
    JHEP REPORTS, 2019, 1 (01) : 30 - 43
  • [38] The regulation of TFEB in lipid homeostasis of non-alcoholic fatty liver disease: Molecular mechanism and promising therapeutic targets
    Yu, Shenglan
    Wang, Zhengtao
    Ding, Lili
    Yang, Li
    LIFE SCIENCES, 2020, 246
  • [39] Yangonin protects against non-alcoholic fatty liver disease through farnesoid X receptor
    Dong Renchan
    Yang, Xiaobo
    Wang, Changyuan
    Liu, Kexin
    Liu, Zhihao
    Ma, Xiaodong
    Sun, Huijun
    Huo, Xiaokui
    Fu, Ting
    Meng, Qiang
    PHYTOMEDICINE, 2019, 53 : 134 - 142
  • [40] Nutritional Assessments of Patients with Non-alcoholic Fatty Liver Disease
    Kim, Chin Hee
    Kallman, Jillian B.
    Bai, ChunHong
    Pawloski, Lisa
    Gewa, Constance
    Arsalla, Aimal
    Sabatella, Mary Ellen
    Younossi, Zobair M.
    OBESITY SURGERY, 2010, 20 (02) : 154 - 160
12345